Schaper Benz & Wise Investment Counsel Inc. WI increased its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 201,747 shares of the pharmacy operator’s stock after buying an additional 3,915 shares during the quarter. Walgreens Boots Alliance comprises about 2.4% of Schaper Benz & Wise Investment Counsel Inc. WI’s holdings, making the stock its 8th largest position. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Walgreens Boots Alliance were worth $15,579,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Commonwealth Bank of Australia lifted its position in Walgreens Boots Alliance by 139.5% in the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after purchasing an additional 26,893 shares during the period. IBM Retirement Fund lifted its position in Walgreens Boots Alliance by 88.1% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after purchasing an additional 10,729 shares during the period. Andra AP fonden lifted its position in Walgreens Boots Alliance by 35.3% in the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after purchasing an additional 15,200 shares during the period. Schwab Charles Investment Management Inc. lifted its position in Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after purchasing an additional 154,995 shares during the period. Finally, Birinyi Associates Inc. lifted its position in Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares during the period. Hedge funds and other institutional investors own 61.18% of the company’s stock.

A number of equities research analysts have recently issued reports on the stock. Royal Bank of Canada assumed coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target for the company. Needham & Company LLC reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Jefferies Group reiterated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, UBS reiterated a “buy” rating and set a $96.00 price target (down from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $86.47.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $72.72 on Thursday. The company has a market cap of $71,850.31, a P/E ratio of 14.23, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.07 EPS. equities analysts anticipate that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.20%. Walgreens Boots Alliance’s payout ratio is currently 42.33%.

Walgreens Boots Alliance announced that its board has approved a stock buyback program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board believes its shares are undervalued.

In other news, Director John Anthony Lederer bought 20,000 shares of the stock in a transaction on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by insiders.

WARNING: “Walgreens Boots Alliance Inc (WBA) Position Boosted by Schaper Benz & Wise Investment Counsel Inc. WI” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/21/walgreens-boots-alliance-inc-wba-position-boosted-by-schaper-benz-wise-investment-counsel-inc-wi.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.